Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects (Q35035808)

5 August 2017

1 reference

title

Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects (English)

1 reference

5 August 2017

0 references

0 references

1

Raphael Mechoulam

1 reference

5 August 2017

Lumír Hanus

2

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Chemistry and Physics of Lipids

5 August 2017

published in

1 reference

5 August 2017

volume

121

1 reference

5 August 2017

issue

1-2

1 reference

5 August 2017

page(s)

35-43

1 reference

Boron triflouride etherate on alimina - a modified Lewis acid reagent

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Metabolites of cannabidiol identified in human urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Urinary metabolites of cannabidiol in dog, rat and man and their identification by gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Hashish: synthesis and central nervous system activity of some novel analogues of cannabidiol and oxepin derivatives of delta 9-tetrahydrocannabinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Hashish. I. The structure of cannabidiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Hashish--13. On the nature of the Beam test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Synthesis and optical rotation of the (-)-cannabidiols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Synthesis of a primary metabolite of cannabidiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2802%2900144-5

10.1016/S0009-3084(02)00144-5

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference